XTAI
1309
Market cap178mUSD
Oct 08, Last price
14.35TWD
1D
-0.35%
1Q
-1.37%
Jan 2017
66.67%
Name
Taita Chemical Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Taita Chemical Company, Limited, established in 1960 and based in Taipei, Taiwan, is a prominent manufacturer and distributor of styrenic polymers. The company's market footprint spans Taiwan, Mainland China, Hong Kong, and the United States. Its primary product offerings include TAITALAC brand acrylonitrile-butadiene-styrene (ABS) resin, a versatile terpolymer plastic. Taita Chemical also produces general purpose and high impact polystyrene under the TAITAREX brand, which are widely employed in the creation of food containers, CD cases, stationery, toys, insulation boards, business machinery, various electronic and electrical appliances, and a range of consumer goods. Additionally, the company supplies TAITACELL brand expandable polystyrene resins. Beyond its core plastics business, Taita Chemical also provides glass wool materials. The firm offers a specialized service in cubic printing, a technique used for applying ornamental finishes to three-dimensional items. This service is utilized across diverse sectors, including automotive components, home electronic devices, IT products, interior decor, sporting equipment, and promotional articles. The company actively participates in international export activities to support its global distribution.
Key people
Chairman of the Board, Chief Executive Officer · since 2009
General Manager, Director · since 2018
Corporate Governance Officer · since 2019
Chunyao Li
Manager of Accounting · since 2024
Feiyun Luo
Head of Finance · since 2024
I-Kung Ma
Director · since 2021
Director · since 2024
Bao-Luo Ying
Director · since 2008
Independent Director · since 2024
Independent Director · since 2015
Kuo-Hsiang Li
Independent Director · since 2021
Independent Director · since 2021
Valuation
Title TWD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||